Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Glaucoma: Overview

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Inhibitory effect of the water-soluble retinoid X receptor partial agonist CAt-PMN on allergic conjunctivitis-like responses in mice.

Experimental eye research·2026

Same author

Modulation of corneal sensory processing and pain responses by dry eye and corneal wounding.

Frontiers in cellular neuroscience·2026

Same author

Corneal Innervation Research at a Crossroads: A Tool-Driven Roadmap for the Future.

Investigative ophthalmology & visual science·2026

Same author

Rexinoid NEt-3IB Promotes Resident Macrophage Gene Expression and Mitigates Desiccation-Induced Ocular Surface Disease.

Investigative ophthalmology & visual science·2026

Same author

Ocular Surface Ulceration Associated With an Epidermal Growth Factor Receptor Inhibitor.

Cornea·2026

Same author

Real-world evaluation of belumosudil for chronic ocular graft-versus-host-disease: Efficacy and outcomes.

Bone marrow transplantation·2026

Same journal

Corneal deformation mapping and FE-based strain analysis via digital image correlation: Biomechanical changes after CXL and laser refractive surgery.

Experimental eye research·2026

Same journal

Tanshinone IIA inhibits choroidal neovascularization and restores outer blood-retinal barrier function in Vldlr knockout mice.

Experimental eye research·2026

Same journal

Understanding the ocular accumulation of mefuparib and its N-dealkylation metabolite: Pharmacokinetics, melanin affinity, and cellular disposition.

Experimental eye research·2026

Same journal

Mitochondrial Dysfunction and Diabetic Retinopathy: Research Progress from Pathogenic Mechanisms to Therapeutic Targets.

Experimental eye research·2026

Same journal

Middle-wavelength green ambient light attenuates lens-induced myopia progression and is associated with suppression of the Wnt/β-catenin signaling pathway in guinea pigs.

Experimental eye research·2026

Same journal

Experimental Corneal Alkali Burn Models: Methodological Standards, Biological Outcomes, and Translational Gaps.

Experimental eye research·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Dec 6, 2025

Establishing a Severe Corneal Inflammation Model in Rats Based on Corneal Epithelium Curettage Combined with Corneal Sutures

Establishing a Severe Corneal Inflammation Model in Rats Based on Corneal Epithelium Curettage Combined with Corneal Sutures

Published on: November 22, 2024

The cornea in keratoconjunctivitis sicca.

Stephen C Pflugfelder¹, Michael E Stern²

¹Department of Ophthalmology, Baylor College of Medicine, Houston, TX, United States.

Experimental Eye Research

|October 10, 2020

Summary

This summary is machine-generated.

Dry eye disease, or keratoconjunctivitis sicca (KCS), damages the cornea by disrupting the tear layer. Effective therapy for dry eye must stabilize tears and reduce inflammation to protect ocular surface health.

Keywords:

Barrier function Cornea epithelium Dry eye Dry eye disease Hyperosmolarity Nociceptor Pain Tear stability

More Related Videos

Author Spotlight: Advancing Research in Corneal Opacity Treatment and Regeneration

Author Spotlight: Advancing Research in Corneal Opacity Treatment and Regeneration

Published on: August 4, 2023

Establishing a Porcine Ex Vivo Cornea Model for Studying Drug Treatments against Bacterial Keratitis

Establishing a Porcine Ex Vivo Cornea Model for Studying Drug Treatments against Bacterial Keratitis

Published on: May 12, 2020

Related Experiment Videos

Last Updated: Dec 6, 2025

Establishing a Severe Corneal Inflammation Model in Rats Based on Corneal Epithelium Curettage Combined with Corneal Sutures

Establishing a Severe Corneal Inflammation Model in Rats Based on Corneal Epithelium Curettage Combined with Corneal Sutures

Published on: November 22, 2024

Author Spotlight: Advancing Research in Corneal Opacity Treatment and Regeneration

Author Spotlight: Advancing Research in Corneal Opacity Treatment and Regeneration

Published on: August 4, 2023

Establishing a Porcine Ex Vivo Cornea Model for Studying Drug Treatments against Bacterial Keratitis

Establishing a Porcine Ex Vivo Cornea Model for Studying Drug Treatments against Bacterial Keratitis

Published on: May 12, 2020

Area of Science:

Ophthalmology
Ocular Surface Disease
Tear Film Dynamics

Background:

The lacrimal functional unit (LFU) maintains the tear film, crucial for corneal health.
Dysfunction of the LFU causes dry eye disease (keratoconjunctivitis sicca, KCS).
KCS involves ocular surface inflammation and epithelial damage.

Purpose of the Study:

To review the pathophysiology of KCS.
To discuss corneal changes associated with KCS.
To outline therapeutic strategies for KCS.

Main Methods:

Literature review of KCS pathophysiology and treatment.
Analysis of corneal changes in KCS.
Synthesis of current therapeutic approaches.

Main Results:

KCS leads to increased tear osmolarity and inflammation.
Corneal changes include glycocalyx loss, barrier disruption, and apoptosis.
Inflammation-induced pain can precede visible clinical signs.

Conclusions:

Therapeutic strategies for KCS should target tear stability and composition.
Improving barrier function and reducing inflammation are key.
Tailored treatment aims to restore corneal epithelial health and visual function.